TEYSUNO: FIRST-LINE CHEMOTHERAPY FOR PATIENTS WITH DISSEMINATED GASTRIC CANCER

TEYSUNO: FIRST-LINE CHEMOTHERAPY FOR PATIENTS WITH DISSEMINATED GASTRIC CANCER

Gastric cancer is one of the leading causes of death among all cancers in Russia. Progression-free and overall survival cannot be drastically changed by current therapeutic approaches. There is a strong need in new drugs for that disease. Teysuno has demonstrated its efficacy in treatment of advance...

Full description

Bibliographic Details
Main Authors: O. O. GORDEEVA, M. E. ABRAMOV, A. N. LUD
Format: Article
Language:Russian
Published: Remedium Group LLC 2017-06-01
Series:Медицинский совет
Subjects:
gastric cancer
teysuno
fluoropyrimidines
Online Access:https://www.med-sovet.pro/jour/article/view/1890
id doaj-1612d33e0d984a78a5af590cd0183a85
record_format Article
spelling doaj-1612d33e0d984a78a5af590cd0183a852021-07-28T13:29:29ZrusRemedium Group LLCМедицинский совет2079-701X2658-57902017-06-0106848610.21518/2079-701X-2017-6-84-861867TEYSUNO: FIRST-LINE CHEMOTHERAPY FOR PATIENTS WITH DISSEMINATED GASTRIC CANCERO. O. GORDEEVA0M. E. ABRAMOV1A. N. LUD2N.N. Blokhin Russian Cancer Research Center, Ministry of Health of RussiaN.N. Blokhin Russian Cancer Research Center, Ministry of Health of RussiaN.N. Blokhin Russian Cancer Research Center, Ministry of Health of RussiaGastric cancer is one of the leading causes of death among all cancers in Russia. Progression-free and overall survival cannot be drastically changed by current therapeutic approaches. There is a strong need in new drugs for that disease. Teysuno has demonstrated its efficacy in treatment of advanced gastric cancer and some other cancers. The more drugs we obtain for clinical practice the more opportunities we can offer for these patients.https://www.med-sovet.pro/jour/article/view/1890gastric cancerteysunofluoropyrimidines
collection DOAJ
language Russian
format Article
sources DOAJ
author O. O. GORDEEVA
M. E. ABRAMOV
A. N. LUD
spellingShingle O. O. GORDEEVA
M. E. ABRAMOV
A. N. LUD
TEYSUNO: FIRST-LINE CHEMOTHERAPY FOR PATIENTS WITH DISSEMINATED GASTRIC CANCER
Медицинский совет
gastric cancer
teysuno
fluoropyrimidines
author_facet O. O. GORDEEVA
M. E. ABRAMOV
A. N. LUD
author_sort O. O. GORDEEVA
title TEYSUNO: FIRST-LINE CHEMOTHERAPY FOR PATIENTS WITH DISSEMINATED GASTRIC CANCER
title_short TEYSUNO: FIRST-LINE CHEMOTHERAPY FOR PATIENTS WITH DISSEMINATED GASTRIC CANCER
title_full TEYSUNO: FIRST-LINE CHEMOTHERAPY FOR PATIENTS WITH DISSEMINATED GASTRIC CANCER
title_fullStr TEYSUNO: FIRST-LINE CHEMOTHERAPY FOR PATIENTS WITH DISSEMINATED GASTRIC CANCER
title_full_unstemmed TEYSUNO: FIRST-LINE CHEMOTHERAPY FOR PATIENTS WITH DISSEMINATED GASTRIC CANCER
title_sort teysuno: first-line chemotherapy for patients with disseminated gastric cancer
publisher Remedium Group LLC
series Медицинский совет
issn 2079-701X
2658-5790
publishDate 2017-06-01
description Gastric cancer is one of the leading causes of death among all cancers in Russia. Progression-free and overall survival cannot be drastically changed by current therapeutic approaches. There is a strong need in new drugs for that disease. Teysuno has demonstrated its efficacy in treatment of advanced gastric cancer and some other cancers. The more drugs we obtain for clinical practice the more opportunities we can offer for these patients.
topic gastric cancer
teysuno
fluoropyrimidines
url https://www.med-sovet.pro/jour/article/view/1890
work_keys_str_mv AT oogordeeva teysunofirstlinechemotherapyforpatientswithdisseminatedgastriccancer
AT meabramov teysunofirstlinechemotherapyforpatientswithdisseminatedgastriccancer
AT anlud teysunofirstlinechemotherapyforpatientswithdisseminatedgastriccancer
_version_ 1721274222640103424

Similar Items